Stock Report

All about this stock under one free report Last Updated: 10-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Zivo Bioscience (ZIVO) Key Ratios

Stock Card factsheet share-fund-plan-icon

$3.11

up-down-arrow $-0.49 (-13.61%)

As on 08-Sep-2026 16:00EDT

Market cap

info icon

$15 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

21.1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -62.48 153.05 -72.26
EBIT -- -- 26.25 -4.48 -3.24
Net Profit 46.14 68.76 43.37 10.97 7.38
EPS 48.07 71.32 47.69 20.41 13.31
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMDec-25Dec-24
EBIT-Margin info -14,348.46-64,662.420.00-8,278.84-8,498.85
Net Margin info -----8,388.36----
Return on equity info 716.60443.30--464.11983.91
Return on Capital info 980.37-562.23--586.851,262.70
Return on Assets info -885.27-603.45-244.90-857.70-1,217.45
Debt to Equity (x) info ----0.00-0.17-0.49

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
586.85
1,262.70
1,091.58
-259.81
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
464.11
983.91
701.76
-289.98
Peer Median
9.42
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-244.90

Lower than Peers by 248.29

Profit after tax / Average Total assets * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-244.90
-857.70
-1,217.45
-580.66
-157.39
Peer Median
3.40
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
-8,278.84
-8,498.85
-26,267.67
-215,604.30
Peer Median
8.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-8,388.36

Lower than Peers by 8,393.14

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-8,388.36
-8,311.12
-8,513.44
-28,127.25
-215,933.16
Peer Median
4.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-62.48

Lower than Peers by 63.02

Year on year growth in net sales

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-62.48
-0.24
4.69
5.83
--
Peer Median
0.54
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
26.25
-83.97
16.82
3.54
Peer Median
-1.72
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

43.37

Higher than Peers by 46.03

Year on year growth in profit after tax

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
43.37
26.09
-72.10
11.07
6.93
Peer Median
-2.66
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

47.69

Higher than Peers by 25.18

Year on year growth in earnings per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
47.69
0.35
0.12
0.20
-4.58
Peer Median
22.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-22.19

Lower than Peers by 30.00

Year on year growth in book value per share

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-22.19
--
--
--
--
Peer Median
7.81
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
-0.17
-0.49
-0.16
-41.91
Peer Median
0.67
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

-0.16

--

(Short term borrowings / Net worth)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-0.16
-0.12
-0.27
-0.16
-31.94
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.10

Lower than Peers by 1.46

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
0.10
0.10
0.80
0.15
0.94
Peer Median
1.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.03

Lower than Peers by 0.79

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
0.03
0.03
--
--
--
Peer Median
0.82
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-141.09

Lower than Peers by 145.40

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-141.09
-283.67
-582.50
-14.13
-655.60
Peer Median
4.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
--
1.41
13.51
--
Peer Median
8.74
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.03

Lower than Peers by 0.62

Sales / Average Total Assets

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
0.03
0.10
0.14
0.02
0.00
Peer Median
0.65
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
6.78
6.91
24.67
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
1,199.72
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
4,062.06
2,889.21
18,859.45
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
-2,855.56
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
-3.93
-5.48
-0.27
-0.45
Peer Median
22.53
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

21.13

Higher than Peers by 19.35

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
21.13
-10.36
-142.40
-0.94
-369.49
Peer Median
1.78
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
--
--
--
--
--
Peer Median
2.62
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-3.01

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
-3.01
-4.01
-5.43
-0.32
-0.29
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

15

Lower than Peers by 626

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Dec-25
Dec-24
Dec-23
Dec-22
Zivo Bioscience (ZIVO)
15
--
--
--
--
Peer Median
641
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...